OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options
Fatemeh Yarmohammadi, Hedyieh Karbasforooshan, A. Wallace Hayes, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2003-2011
Closed Access | Times Cited: 42
Fatemeh Yarmohammadi, Hedyieh Karbasforooshan, A. Wallace Hayes, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2021) Vol. 394, Iss. 10, pp. 2003-2011
Closed Access | Times Cited: 42
Showing 26-50 of 42 citing articles:
Noninvasive neuromodulation protects against doxorubicin-induced cardiotoxicity and inhibits tumor growth
Mengjie Xie, Fuding Guo, Lingpeng Song, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109163-109163
Open Access | Times Cited: 2
Mengjie Xie, Fuding Guo, Lingpeng Song, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109163-109163
Open Access | Times Cited: 2
Serum and glucocorticoid-regulated kinase 1 (SGK1) as an emerging therapeutic target for cardiac diseases
Fatemeh Yarmohammadi, Gholamreza Karimi
Pharmacological Research (2024) Vol. 208, pp. 107369-107369
Open Access | Times Cited: 2
Fatemeh Yarmohammadi, Gholamreza Karimi
Pharmacological Research (2024) Vol. 208, pp. 107369-107369
Open Access | Times Cited: 2
Circ_0001312 Silencing Suppresses Doxorubicin-Induced Cardiotoxicity via MiR-409-3p/HMGB1 Axis
Xiaochun Hu, Liao Wang, Lifeng Teng, et al.
International Heart Journal (2023) Vol. 64, Iss. 1, pp. 71-80
Open Access | Times Cited: 7
Xiaochun Hu, Liao Wang, Lifeng Teng, et al.
International Heart Journal (2023) Vol. 64, Iss. 1, pp. 71-80
Open Access | Times Cited: 7
CTRP5 Attenuates Doxorubicin-Induced Cardiotoxicity Via Inhibiting TLR4/NLRP3 Signaling
Zhaoxia Zhang, Jianye Peng, Yewen Hu, et al.
Cardiovascular Drugs and Therapy (2023)
Closed Access | Times Cited: 5
Zhaoxia Zhang, Jianye Peng, Yewen Hu, et al.
Cardiovascular Drugs and Therapy (2023)
Closed Access | Times Cited: 5
Targeting PPARs Signaling Pathways in Cardiotoxicity by Natural Compounds
Fatemeh Yarmohammadi, A. Wallace Hayes, Gholamreza Karimi
Cardiovascular Toxicology (2022) Vol. 22, Iss. 4, pp. 281-291
Closed Access | Times Cited: 9
Fatemeh Yarmohammadi, A. Wallace Hayes, Gholamreza Karimi
Cardiovascular Toxicology (2022) Vol. 22, Iss. 4, pp. 281-291
Closed Access | Times Cited: 9
The cardioprotective potentials and the involved mechanisms of phenolic acids in drug-induced cardiotoxicity
Xianfeng Liu, Ruimin Tian, Honglin Tao, et al.
European Journal of Pharmacology (2022) Vol. 936, pp. 175362-175362
Closed Access | Times Cited: 9
Xianfeng Liu, Ruimin Tian, Honglin Tao, et al.
European Journal of Pharmacology (2022) Vol. 936, pp. 175362-175362
Closed Access | Times Cited: 9
Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions
Chao Huang, Xiaoxia Li, Hanqing Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Chao Huang, Xiaoxia Li, Hanqing Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Upregulation of Biomarker Limd1 Was Correlated with Immune Infiltration in Doxorubicin-Related Cardiotoxicity
Rui Zhang, Chunshu Hao, Zhenjun Ji, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-23
Open Access | Times Cited: 2
Rui Zhang, Chunshu Hao, Zhenjun Ji, et al.
Mediators of Inflammation (2023) Vol. 2023, pp. 1-23
Open Access | Times Cited: 2
The Role of mTOR in Doxorubicin-Altered Cardiac Metabolism: A Promising Therapeutic Target of Natural Compounds
Fatemeh Yarmohammadi, Mahvash Hesari, Dareuosh Shackebaei
Cardiovascular Toxicology (2023) Vol. 24, Iss. 2, pp. 146-157
Closed Access | Times Cited: 2
Fatemeh Yarmohammadi, Mahvash Hesari, Dareuosh Shackebaei
Cardiovascular Toxicology (2023) Vol. 24, Iss. 2, pp. 146-157
Closed Access | Times Cited: 2
Protective effects and structure-activity relationship of oligopeptide AYAPE from Isochrysis Zhanjiangensis on oxidative stress in HUVECs and SH-SY5Y cells
Huijuan Li, Liyuan Li, Yinhuan Mo, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 3, pp. 105633-105633
Open Access
Huijuan Li, Liyuan Li, Yinhuan Mo, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 3, pp. 105633-105633
Open Access
Immunomodulatory potential of silver nanoparticles and therapeutic effect against doxorubicin-induced-cardiotoxicity in rats
Nesrin I. Tarbiah, Fares K. Khalifa, Nuha A. Alkhattabi, et al.
The Annals of Clinical and Analytical Medicine (2024) Vol. 15, Iss. 03
Open Access
Nesrin I. Tarbiah, Fares K. Khalifa, Nuha A. Alkhattabi, et al.
The Annals of Clinical and Analytical Medicine (2024) Vol. 15, Iss. 03
Open Access
Molecular mechanisms involved in therapeutic effects of natural compounds against cisplatin-induced cardiotoxicity: a review
Mahvash Hesari, Pantea Mohammadi, Mojtaba Moradi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Mahvash Hesari, Pantea Mohammadi, Mojtaba Moradi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Pleiotropic role of CCR9/CCL25 signaling in adriamycin-induced cardiomyopathy
Xue Wu, Zheng Wang, Zibin Liang, et al.
Journal of Advanced Research (2024)
Open Access
Xue Wu, Zheng Wang, Zibin Liang, et al.
Journal of Advanced Research (2024)
Open Access
Preventive effect of imperatorin against doxorubicin-induced cardiotoxicity through suppression of NLRP3 inflammasome activation
Hao Zhang, Xiaoyun Ding, Yumei Qiu, et al.
Journal of Natural Medicines (2024)
Closed Access
Hao Zhang, Xiaoyun Ding, Yumei Qiu, et al.
Journal of Natural Medicines (2024)
Closed Access
Prx5 overexpression protect against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via the TLR4/NF-κB pathway
Yewen Hu, Shiqi Wang, Chaoxia Zhang, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113788-113788
Closed Access
Yewen Hu, Shiqi Wang, Chaoxia Zhang, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113788-113788
Closed Access
Gab1 overexpression alleviates doxorubicin-induced cardiac oxidative stress, inflammation, and apoptosis through PI3K/Akt signaling pathway
Zhaoxia Zhang, Caijie Shen, Nan Wu, et al.
Journal of Cardiovascular Pharmacology (2022) Vol. 80, Iss. 6, pp. 804-812
Closed Access | Times Cited: 3
Zhaoxia Zhang, Caijie Shen, Nan Wu, et al.
Journal of Cardiovascular Pharmacology (2022) Vol. 80, Iss. 6, pp. 804-812
Closed Access | Times Cited: 3
Anti-inflammatory effect of omega-7 against doxorubicin-induced cardiotoxicity in male rats: An observational study
Mohammed H. Fadhel, Ali Faris Hassan
F1000Research (2023) Vol. 12, pp. 36-36
Open Access
Mohammed H. Fadhel, Ali Faris Hassan
F1000Research (2023) Vol. 12, pp. 36-36
Open Access
Effect of Cancer Stem Cell on Cardio-toxicity: Molecular Mechanism and Future Approach
Iranian Red Crescent Medical Journal (2023)
Open Access
Iranian Red Crescent Medical Journal (2023)
Open Access
